Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01744184
Other study ID # ENT1
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date May 2013
Est. completion date December 2020

Study information

Verified date January 2020
Source The Royal Bournemouth Hospital
Contact Simon McLaughlin, MD
Phone 01202704961
Email simon.mclaughlin@nhs.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to determine whether Entonox (gas and air) is at least as good as intravenous midazolam in providing analgesia and sedation during gastroscopy. Entonox is used as an adjunct in lower gastrointestinal procedures but is not routinely used in gastroscopy, and there is only one similar published study to date, which was performed in children. The main advantage of Entonox over midazolam is the quick recovery time following withdrawal of the agent, which enables patients to return to independent normal life. The investigators would like to be able to offer Entonox to patients as an option for sedation during gastroscopy, this study is being conducted to determine if it is a safe and feasible option.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 2020
Est. primary completion date April 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male/female aged 18 years or over

- Confirmed clinical requirement to undergo diagnostic gastroscopy

- Suitable for sedation

- Able to provide informed consent

Exclusion Criteria:

- History of chronic respiratory or significant cardiac disease

- Requirement for longer procedure eg Barrett's surveillance

- Previous known adverse reaction to Entonox

- Entonox use in previous 4 days

- Known current vitamin B12 or folate deficiency

- Unable to provide consent

- Any known contraindication to Entonox:

- Gas trapped in a part of the body where its expansion may be dangerous, such as air lodged in an artery or artificial traumatic or spontaneous pneumothorax (collapsed lung).

- Decompression sickness (the bends) or following a recent dive

- Air encephalography

- Severe bullous emphysema

- Myringoplasty

- Gross abdominal distension

- Recent severe injuries to the face and jaw

- Current or recent head injuries

- If the patient has recently had any eye surgery where injections of gas have been used

Study Design


Related Conditions & MeSH terms

  • Patients Requiring Diagnostic Gastroscopy With Sedation

Intervention

Drug:
Entonox
Entonox arm
Midazolam
up to 5mg midazolam as appropriate

Locations

Country Name City State
United Kingdom The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust Bournemouth Dorset

Sponsors (1)

Lead Sponsor Collaborator
The Royal Bournemouth Hospital

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient comfort during gastroscopy Patient comfort during gastroscopy confirmed by post procedural questionnaire completion During gastroscopy procedure
Secondary Number of completed procedures in both arms of the study. The number of completed procedures in both arms of the study confirmed by data collection. 3 months